Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial.
Del Barco S, Colomer R, Calvo L, Tusquets I, Adrover E, Sánchez P, Rifà J, De la Haba J, Virizuela JA. Del Barco S, et al. Breast Cancer Res Treat. 2009 Jul;116(2):351-8. doi: 10.1007/s10549-008-0218-8. Epub 2008 Oct 22. Breast Cancer Res Treat. 2009. PMID: 18941891 Clinical Trial.
Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C, Vazquez-Martin A, López-Bonet E, Martín-Castillo B, Del Barco S, Brunet J, Menendez JA. Oliveras-Ferraros C, et al. Among authors: del barco s. Int J Oncol. 2008 Dec;33(6):1165-76. Int J Oncol. 2008. PMID: 19020749
Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin).
Oliveras-Ferraros C, Vazquez-Martin A, Martin-Castilló B, Pérez-Martínez MC, Cufí S, Del Barco S, Bernado L, Brunet J, López-Bonet E, Menendez JA. Oliveras-Ferraros C, et al. Among authors: del barco s. Int J Oncol. 2010 Sep;37(3):669-78. doi: 10.3892/ijo_00000716. Int J Oncol. 2010. PMID: 20664936
SEOM clinical guideline for treatment of cancer pain (2017).
Jara C, Del Barco S, Grávalos C, Hoyos S, Hernández B, Muñoz M, Quintanar T, Meana JA, Rodriguez C, de Las Peñas R. Jara C, et al. Among authors: del barco s. Clin Transl Oncol. 2018 Jan;20(1):97-107. doi: 10.1007/s12094-017-1791-2. Epub 2017 Nov 10. Clin Transl Oncol. 2018. PMID: 29127593 Free PMC article.
Geriatric oncology in Spain: survey results and analysis of the current situation.
Gironés R, Morilla I, Guillen-Ponce C, Torregrosa MD, Paredero I, Bustamante E, Del Barco S, Soler G, Losada B, Visa L, Llabrés E, Fox B, Firvida JL, Blanco R, Antonio M, Aparisi F, Pi-Figueras M, Gonzalez-Flores E, Molina-Garrido MJ, Saldaña J; Spanish Working Group on Geriatric Oncology of the Spanish Society of Medical Oncology (SEOM). Gironés R, et al. Among authors: del barco s. Clin Transl Oncol. 2018 Aug;20(8):1087-1092. doi: 10.1007/s12094-017-1813-0. Epub 2017 Dec 11. Clin Transl Oncol. 2018. PMID: 29327240 Free PMC article.
54 results